Therapeutic agent for bile duct cancer
US12364690B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 19, 2018 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Dec 19, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.